Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Current Deferred Tax Assets: 2013-2015

Historic Current Deferred Tax Assets for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Sep 2015 value amounting to $19.2 million.

  • Amphastar Pharmaceuticals' Current Deferred Tax Assets rose 19.14% to $19.2 million in Q3 2015 from the same period last year, while for Sep 2015 it was $19.2 million, marking a year-over-year increase of 19.14%. This contributed to the annual value of $19.5 million for FY2014, which is 21.35% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Current Deferred Tax Assets stood at $19.2 million for Q3 2015, which was down 0.00% from $19.2 million recorded in Q2 2015.
  • In the past 5 years, Amphastar Pharmaceuticals' Current Deferred Tax Assets ranged from a high of $19.7 million in Q1 2015 and a low of $16.1 million during Q4 2013.
  • Moreover, its 3-year median value for Current Deferred Tax Assets was $19.2 million (2015), whereas its average is $18.0 million.
  • Data for Amphastar Pharmaceuticals' Current Deferred Tax Assets shows a peak YoY increased of 21.35% (in 2014) over the last 5 years.
  • Over the past 3 years, Amphastar Pharmaceuticals' Current Deferred Tax Assets (Quarterly) stood at $16.1 million in 2013, then grew by 21.35% to $19.5 million in 2014, then grew by 19.14% to $19.2 million in 2015.
  • Its Current Deferred Tax Assets was $19.2 million in Q3 2015, compared to $19.2 million in Q2 2015 and $19.7 million in Q1 2015.